ChorChek, Inc. – Trademark Portfolio

Entity Type: 03

ChorChek, Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include VF, VERIFOOD, and VF VERIFOOD. The owner is based in Ulysses, NE.

940 28th Road

Ulysses, NE 68669

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

VERIFOOD
VERIFOOD
Registered 2021
VF
VF
Registered 2021

Trademark Classifications

ChorChek, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (3 filings)

Scientific and technological services; industrial analysis and research services

44
Medical Services (3 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does ChorChek, Inc. have?

ChorChek, Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does ChorChek, Inc. file in?

ChorChek, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.

What are ChorChek, Inc.'s most well-known trademarks?

ChorChek, Inc.'s registered trademark portfolio includes well-known marks such as VF, VERIFOOD, and VF VERIFOOD. These are among 3 currently registered trademarks in the portfolio.

What is ChorChek, Inc.'s trademark registration success rate?

ChorChek, Inc. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.